HeimSWOBY ⢠OTCMKTS
add
Swedish Orphan Biovitrum ADR
ViĂ° sĂĂ°ustu lokun
21,56Â $
Ărabil
13,57Â $ - 23,59Â $
MarkaĂ°svirĂ°i
146,54Â ma. SEK
MeĂ°almagn
465,00
V/H-hlutf.
-
A/V-hlutfall
-
ViĂ°skiptafrĂŠttir
EBC Financial Group
fyrir 1 klukkustund
Dow Jones Index Today: When a Few Stocks Move the Whole Market
0,59%
0,63%
FjĂĄrmĂĄl
Rekstrarreikningur
Tekjur
NettĂłtekjur
| (SEK) | des. 2025info | Breyting ĂĄ/ĂĄ |
|---|---|---|
Tekjur | 7,82Â ma. | 5,19% |
RekstrarkostnaĂ°ur | 3,75Â ma. | -10,07% |
NettĂłtekjur | 1,86Â ma. | 33,29% |
HagnaĂ°arhlutfall | 23,81 | 26,72% |
HagnaĂ°ur ĂĄ hvern hlut | 5,65 | 41,96% |
EBITDA | 3,13Â ma. | 33,48% |
Virkt skatthlutfall | 14,27% | â |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (SEK) | des. 2025info | Breyting ĂĄ/ĂĄ |
|---|---|---|
ReiĂ°ufĂŠ og skammtĂmafjĂĄrfestingar | 1,04Â ma. | -8,68% |
Heildareignir | 67,43Â ma. | -10,62% |
Heildarskuldir | 29,71Â ma. | -15,47% |
EigiĂ° fĂŠ alls | 37,72Â ma. | â |
Ătistandandi hlutabrĂŠf | 345,66Â m. | â |
EiginfjĂĄrgengi | 0,20 | â |
ArĂ°semi eigna | 9,51% | â |
ĂvĂśxtun eigin fjĂĄr | 12,94% | â |
PeningaflĂŚĂ°i
Breyting ĂĄ handbĂŚru fĂŠ
| (SEK) | des. 2025info | Breyting ĂĄ/ĂĄ |
|---|---|---|
NettĂłtekjur | 1,86Â ma. | 33,29% |
HandbĂŚrt fĂŠ frĂĄ rekstri | 2,98Â ma. | 65,89% |
ReiĂ°ufĂŠ frĂĄ fjĂĄrfestingum | -1,08Â ma. | -966,34% |
ReiĂ°ufĂŠ frĂĄ fjĂĄrmĂśgnun | -1,90Â ma. | -65,13% |
Breyting ĂĄ handbĂŚru fĂŠ | 2,00Â m. | -99,63% |
FrjĂĄlst peningaflĂŚĂ°i | 2,86Â ma. | -1,53% |
Um
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
FramkvĂŚmdastjĂłri
Stofnsett
1939
VefsvĂŚĂ°i
StarfsfĂłlk
1.862
